Cornerstone Advisory, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Cornerstone Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 20, 2022	SELL	$0.32 - $0.67 $331 - $693	-1,035 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$0.6 - $1.11 $11,442 - $21,167	-19,070 Reduced 94.85%	1,035 $0
Q3 2021 Nov 16, 2021	BUY	$1.01 - $1.82 $106 - $191	105 Added 0.53%	20,105 $20,000
Q1 2021 May 13, 2021	BUY	$1.27 - $3.42 $25,400 - $68,400	20,000 New	20,000 $40,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.64B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Cornerstone Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Cornerstone Advisory, LLC with notifications on news.